Skip to content

PhilClapharma: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PhilClapharma

BE 0675.782.469
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€18,464
2024 · €36,909-€18,446
Equity
€338,220
2024 · €319,756+€18,464
Cash
€9,009
2024 · €8,740+€270
Balance sheet total
€867,932
2024 · €869,621-€1,689

Largest movements

2024 to 2025
Assets

No asset line moved by more than 1% of the balance sheet total.

    Equity and liabilities
    • Debts after one year -€49,483

      down €49,483 (-11.3%), from €438,391 to €388,908

      of which Financial debts: -€49,483

    • Reserves +€18,464

      up €18,464 (+6.4%), from €289,756 to €308,220

      of which Distributable reserves: +€21,464

    • Advances received +€12,100

      new in 2025: €12,100

    • Trade debts +€9,046

      up €9,046 (+409.7%), from €2,208 to €11,254

    Income statement
    • Gross operating margin -€14,773

      down €14,773 (-21.5%), from €68,833 to €54,060

    • Financial charges +€8,525

      up €8,525 (+94.4%), from €9,035 to €17,560

    • Taxes -€5,218

      down €5,218 (-35.7%), from €14,597 to €9,380

    From the 2024 result to the 2025 result

    effect on the result

    Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

    Result 2024 €36,909
    Gross operating margin -€14,773
    Other operating charges -€366
    Financial charges -€8,525
    Taxes +€5,218
    Result 2025 €18,464

    Cash bridge derived

    cash 2024 to 2025

    Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

    From operations +€48,918
    Investment €0
    Financing -€48,649
    Cash 2024 €8,740
    Net result for the year +€18,464
    Depreciation +€7,621
    Receivables within one year -€5,499
    Deferred charges and accrued income -€163
    Trade debts +€9,046
    Tax, wage and social debts -€298
    Advances received +€12,100
    Other debts +€7,630
    Accrued charges and deferred income +€18
    Debts after one year -€49,483
    Current portion of long-term debt +€6,017
    Short-term financial debts -€5,183
    Cash 2025 €9,009
    Every line side by side 43 lines
    Line Code 2024 2025 Change %
    Total assets 20/58 €869,621 €867,932 -€1,689 -0.2%
    Fixed assets 21/28 €857,109 €849,488 -€7,621 -0.9%
    Tangible fixed assets 22/27 €30,274 €22,653 -€7,621 -25.2%
    Furniture and vehicles 24 €30,274 €22,653 -€7,621 -25.2%
    Financial fixed assets 28 €826,835 €826,835 = 0.0%
    Current assets 29/58 €12,513 €18,444 +€5,931 +47.4%
    Amounts receivable within one year 40/41 €1,351 €6,850 +€5,499 +407.0%
    Trade receivables 40 €861 €1,893 +€1,032 +119.9%
    Other amounts receivable 41 €491 €4,957 +€4,467 +910.6%
    Cash at bank and in hand 54/58 €8,740 €9,009 +€270 +3.1%
    Deferred charges and accrued income 490/1 €2,422 €2,584 +€163 +6.7%
    Total equity and liabilities 10/49 €869,621 €867,932 -€1,689 -0.2%
    Equity 10/15 €319,756 €338,220 +€18,464 +5.8%
    Contributions 10/11 €30,000 €30,000 = 0.0%
    Reserves 13 €289,756 €308,220 +€18,464 +6.4%
    Non-distributable reserves 130/1 €3,000 - -€3,000
    Reserves not available under the articles 1311 €3,000 - -€3,000
    Distributable reserves 133 €286,756 €308,220 +€21,464 +7.5%
    Amounts payable 17/49 €549,865 €529,712 -€20,153 -3.7%
    Amounts payable after more than one year 17 €438,391 €388,908 -€49,483 -11.3%
    Financial debts 170/4 €318,391 €268,908 -€49,483 -15.5%
    Other amounts payable 178/9 €120,000 €120,000 = 0.0%
    Amounts payable within one year 42/48 €111,474 €140,787 +€29,313 +26.3%
    Current portion of amounts payable after more than one year 42 €48,390 €54,407 +€6,017 +12.4%
    Financial debts 43 €5,183 €0 -€5,183 -100.0%
    Credit institutions 430/8 €5,183 €0 -€5,183 -100.0%
    Trade debts 44 €2,208 €11,254 +€9,046 +409.7%
    Suppliers 440/4 €2,208 €11,254 +€9,046 +409.7%
    Advances received on contracts in progress 46 - €12,100 +€12,100
    Taxes, remuneration and social security 45 €6,282 €5,984 -€298 -4.7%
    Taxes 450/3 €6,282 €5,984 -€298 -4.7%
    Other amounts payable 47/48 €49,412 €57,042 +€7,630 +15.4%
    Accrued charges and deferred income 492/3 - €18 +€18
    Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,621 €7,621 = 0.0%
    Other operating charges 640/8 €671 €1,036 +€366 +54.5%
    Gross operating margin 9900 €68,833 €54,060 -€14,773 -21.5%
    Operating profit (loss) 9901 €60,541 €45,403 -€15,138 -25.0%
    Financial charges 65/66B €9,035 €17,560 +€8,525 +94.4%
    Recurring financial charges 65 €9,035 €17,560 +€8,525 +94.4%
    Profit (loss) for the period before taxes 9903 €51,507 €27,843 -€23,663 -45.9%
    Income taxes 67/77 €14,597 €9,380 -€5,218 -35.7%
    Profit (loss) for the period 9904 €36,909 €18,464 -€18,446 -50.0%
    Profit (loss) for the period to be appropriated 9905 €36,909 €18,464 -€18,446 -50.0%

    Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.